Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder

NCT01857596 is registered in ClinicalTrials.gov with S1 Biopharma, Inc. as lead sponsor.

NCT NCT01857596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01857596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder
Lead sponsor
S1 Biopharma, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2013
Completion date
October 31, 2014
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypoactive sexual desire disorder (dsm-iv-tr defined), sexual interest/arousal disorder (dsm-5 defined)